WO2004039427A3 - Transdermal delivery system for anti-emetic medication - Google Patents
Transdermal delivery system for anti-emetic medication Download PDFInfo
- Publication number
- WO2004039427A3 WO2004039427A3 PCT/IL2003/000902 IL0300902W WO2004039427A3 WO 2004039427 A3 WO2004039427 A3 WO 2004039427A3 IL 0300902 W IL0300902 W IL 0300902W WO 2004039427 A3 WO2004039427 A3 WO 2004039427A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- delivery system
- transdermal delivery
- hydrophilic
- emetic
- emetic medication
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
- A61N1/0496—Patch electrodes characterised by using specific chemical compositions, e.g. hydrogel compositions, adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004547954A JP2006509739A (en) | 2002-10-31 | 2003-10-30 | Anti-emetic transdermal delivery system |
AU2003276656A AU2003276656A1 (en) | 2002-10-31 | 2003-10-30 | Transdermal delivery system for anti-emetic medication |
EP03809829.9A EP1556135B1 (en) | 2002-10-31 | 2003-10-30 | Transdermal delivery system for anti-emetic medication |
US11/116,065 US7415306B2 (en) | 2002-10-31 | 2005-04-27 | Transdermal delivery system for anti-emetic medication |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL152573A IL152573A (en) | 2002-10-31 | 2002-10-31 | Transdermal delivery system for anti-emetic medication |
IL152573 | 2002-10-31 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/116,065 Continuation US7415306B2 (en) | 2002-10-31 | 2005-04-27 | Transdermal delivery system for anti-emetic medication |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004039427A2 WO2004039427A2 (en) | 2004-05-13 |
WO2004039427A3 true WO2004039427A3 (en) | 2004-09-23 |
Family
ID=29765102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2003/000902 WO2004039427A2 (en) | 2002-10-31 | 2003-10-30 | Transdermal delivery system for anti-emetic medication |
Country Status (6)
Country | Link |
---|---|
US (1) | US7415306B2 (en) |
EP (1) | EP1556135B1 (en) |
JP (1) | JP2006509739A (en) |
AU (1) | AU2003276656A1 (en) |
IL (1) | IL152573A (en) |
WO (1) | WO2004039427A2 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003226605A1 (en) | 2002-04-19 | 2003-11-03 | Transpharma Medical Ltd. | Handheld transdermal drug delivery and analyte extraction |
JP5015594B2 (en) * | 2003-06-23 | 2012-08-29 | トランスファーマ メディカル リミテッド | Transdermal delivery system for cosmetics |
IL160033A0 (en) | 2004-01-25 | 2004-06-20 | Transpharma Medical Ltd | Transdermal delivery system for polynucleotides |
AU2005231443B2 (en) | 2004-04-01 | 2012-02-23 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
WO2006025070A2 (en) | 2004-07-30 | 2006-03-09 | Torrent Pharmaceuticals Limited | Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
US20070264319A1 (en) * | 2004-09-01 | 2007-11-15 | Lebo David B | Transdermal Antiemesis Delivery System, Method and Composition Therefor |
JP2008520331A (en) | 2004-11-18 | 2008-06-19 | トランスファーマ メディカル リミテッド | Combined microchannel formation and iontophoresis for transdermal delivery of drugs |
US8467868B1 (en) * | 2005-04-26 | 2013-06-18 | University Of South Florida | Method of transdermal drug delivery |
US20060263421A1 (en) | 2005-05-18 | 2006-11-23 | Abeille Pharmaceuticals Inc | Transdermal Method and Patch for Nausea |
CA2610757A1 (en) * | 2005-06-10 | 2006-12-14 | Transpharma Medical, Ltd. | Patch for transdermal drug delivery |
US20070009542A1 (en) | 2005-07-05 | 2007-01-11 | Galit Levin | Method and device for transdermal immunization |
JP5037831B2 (en) * | 2006-02-15 | 2012-10-03 | 久光製薬株式会社 | External patch for improving cohesion and sustained release |
JP2008297277A (en) * | 2007-06-01 | 2008-12-11 | Taiyo Yakuhin Kogyo Kk | Method for stabilizing parenteral injection |
CA2704740C (en) * | 2007-10-09 | 2016-05-17 | Transpharma Ltd. | Magnetic patch coupling |
JP5612474B2 (en) * | 2007-10-17 | 2014-10-22 | トランスファーマ メディカル リミテッド | Verification of dissolution rate |
CA2704164A1 (en) * | 2007-10-29 | 2009-05-07 | Transpharma Medical Ltd. | Vertical patch drying |
WO2009072108A2 (en) | 2007-12-05 | 2009-06-11 | Syneron Medical Ltd. | A disposable electromagnetic energy applicator and method of using it |
JP5547065B2 (en) | 2008-05-15 | 2014-07-09 | 久光製薬株式会社 | Transdermal absorption preparation containing palonosetron |
US8357150B2 (en) | 2009-07-20 | 2013-01-22 | Syneron Medical Ltd. | Method and apparatus for fractional skin treatment |
US8606366B2 (en) | 2009-02-18 | 2013-12-10 | Syneron Medical Ltd. | Skin treatment apparatus for personal use and method for using same |
US20110009782A1 (en) * | 2009-07-07 | 2011-01-13 | Naya Touch, Inc. | Dermal roller with therapeutic microstructures |
US20120225112A1 (en) * | 2011-03-03 | 2012-09-06 | Mark Stephen Saia | Method and Apparatus for Alcohol Administration |
USD733899S1 (en) | 2011-09-30 | 2015-07-07 | Nse Products, Inc. | Skin treatment device |
BR112014021653B1 (en) | 2012-03-01 | 2023-03-28 | Firststring Research, Inc. | TOPICAL FORMULATION, USE OF THE TOPICAL FORMULATION AND METHOD FOR MANUFACTURING A TOPICAL FORMULATION |
KR101979746B1 (en) | 2012-09-13 | 2019-05-17 | (주)아모레퍼시픽 | Device and Method for Electroporation |
WO2014122627A1 (en) | 2013-02-11 | 2014-08-14 | Glycanova As | Basidiomycete-derived cream for treatment of skin diseases |
US11534608B2 (en) | 2015-01-04 | 2022-12-27 | Ist, Llc | Methods and apparatuses for transdermal stimulation of the outer ear |
CN105168185B (en) * | 2015-08-03 | 2018-06-15 | 王剑峰 | A kind of external application for sleep-disorder auxiliary treatment applies and preparation method thereof |
CN108310986A (en) * | 2017-11-10 | 2018-07-24 | 中国海洋大学 | A kind of NF membrane and preparation method thereof |
CN113286579A (en) * | 2018-08-23 | 2021-08-20 | 埃里克·F·伯恩斯坦 | Systems, devices and methods for using anti-VEGF compounds and treating skin disorders using such compounds |
WO2020150737A1 (en) * | 2019-01-18 | 2020-07-23 | Ist, Llc | Methods and devices for modulation of integrated neural networks to influence composite sensory processes |
USD933840S1 (en) | 2020-04-21 | 2021-10-19 | Nse Products, Inc. | Microcurrent skin treatment device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5320597A (en) * | 1991-02-08 | 1994-06-14 | Becton, Dickinson And Company | Device and method for renewing electrodes during iontophoresis |
US5983130A (en) * | 1995-06-07 | 1999-11-09 | Alza Corporation | Electrotransport agent delivery method and apparatus |
US5993435A (en) * | 1990-04-30 | 1999-11-30 | Alza Corporation | Device and method of iontophoretic drug delivery |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3964482A (en) | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
US4559222A (en) | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
US4725439A (en) | 1984-06-29 | 1988-02-16 | Alza Corporation | Transdermal drug delivery device |
US4704282A (en) | 1984-06-29 | 1987-11-03 | Alza Corporation | Transdermal therapeutic system having improved delivery characteristics |
EP0186019B1 (en) | 1984-12-22 | 1993-10-06 | Schwarz Pharma Ag | Medicated dressing |
DE68925030T2 (en) | 1988-01-21 | 1996-07-25 | Massachusetts Inst Technology | MOLECULE TRANSPORT THROUGH FABRICS WITH THE USE OF ELECTROPORATION. |
DE3910543A1 (en) | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | TRANSDERMAL THERAPEUTIC SYSTEM WITH INCREASED ACTIVE FLUID AND METHOD FOR THE PRODUCTION THEREOF |
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
DE4014913C2 (en) | 1990-05-10 | 1996-05-15 | Lohmann Therapie Syst Lts | Miniaturized transdermal therapeutic system for iontophoresis |
US5158537A (en) | 1990-10-29 | 1992-10-27 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
US5152997A (en) | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
ES2065181T3 (en) * | 1991-03-11 | 1995-02-01 | Alza Corp | IONTOPHORETICAL SUPPLY DEVICE AND PROCEDURE FOR ITS MANUFACTURE. |
DK0643600T3 (en) | 1992-06-02 | 1998-06-02 | Alza Corp | Iontophoretic drug delivery apparatus |
US5622944A (en) | 1992-06-12 | 1997-04-22 | Affymax Technologies N.V. | Testosterone prodrugs for improved drug delivery |
US5989586A (en) | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
US5807306A (en) | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
US5445609A (en) | 1993-05-28 | 1995-08-29 | Alza Corporation | Electrotransport agent delivery device having a disposable component and a removable liner |
US5460820B1 (en) | 1993-08-03 | 1999-08-03 | Theratech Inc | Method for providing testosterone and optionally estrogen replacement therapy to women |
US5885211A (en) | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
US5576311A (en) | 1994-11-30 | 1996-11-19 | Pharmos Corporation | Cyclodextrins as suspending agents for pharmaceutical suspensions |
DE19525607A1 (en) * | 1995-07-14 | 1997-01-16 | Boehringer Ingelheim Kg | Transcorneal drug delivery system |
US5840327A (en) | 1995-08-21 | 1998-11-24 | Alza Corporation | Transdermal drug delivery device having enhanced adhesion |
TR199800347T1 (en) | 1995-08-29 | 1998-05-21 | Spectrx, Inc. | Micro-poring of human skin for drug application and monitoring applications. |
US5824668A (en) | 1996-11-07 | 1998-10-20 | Supergen, Inc. | Formulation for administration of steroid compounds |
AU1429697A (en) | 1995-12-29 | 1997-07-28 | Cygnus, Inc. | Systems and methods for the transdermal administration of androgenic agents |
US5944685A (en) | 1996-02-09 | 1999-08-31 | Polytronics, Ltd. | Skin-contact type medical treatment apparatus |
WO1998017315A2 (en) | 1996-10-24 | 1998-04-30 | Alza Corporation | Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
AU735944B2 (en) | 1997-02-28 | 2001-07-19 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of testosterone |
US5874418A (en) | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
US6046177A (en) | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
AU3170697A (en) * | 1997-05-30 | 1998-12-30 | Minnesota Mining And Manufacturing Company | Transdermal drug delivery device for the delivery of tropisetron or granisetron |
US5851438A (en) | 1997-08-29 | 1998-12-22 | E. I. Du Pont De Nemours And Company | Thick film compositions for making medical electrodes |
CA2313458C (en) | 1997-12-11 | 2007-04-17 | Alza Corporation | Device for enhancing transdermal agent flux |
US6083196A (en) | 1997-12-11 | 2000-07-04 | Alza Corporation | Device for enhancing transdermal agent flux |
US6173202B1 (en) | 1998-03-06 | 2001-01-09 | Spectrx, Inc. | Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
US6022316A (en) | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
US6219577B1 (en) | 1998-04-14 | 2001-04-17 | Global Vascular Concepts, Inc. | Iontophoresis, electroporation and combination catheters for local drug delivery to arteries and other body tissues |
US6708060B1 (en) | 1998-11-09 | 2004-03-16 | Transpharma Ltd. | Handheld apparatus and method for transdermal drug delivery and analyte extraction |
US6611706B2 (en) | 1998-11-09 | 2003-08-26 | Transpharma Ltd. | Monopolar and bipolar current application for transdermal drug delivery and analyte extraction |
US6597946B2 (en) | 1998-11-09 | 2003-07-22 | Transpharma Ltd. | Electronic card for transdermal drug delivery and analyte extraction |
US6148232A (en) * | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
US5983135A (en) | 1998-12-24 | 1999-11-09 | Avrahami; Zohar | Transdermal delivery of fine powders |
CN1209108C (en) * | 1999-02-09 | 2005-07-06 | 株式会社三养社 | Transdermal composition of antivomiting agent and preparation containing the same |
EP1150741A1 (en) | 1999-02-10 | 2001-11-07 | GMP Drug Delivery, Inc. | Iontophoresis, electroporation and combination patches for local drug delivery |
CA2376797C (en) | 1999-06-11 | 2011-03-22 | Watson Pharmaceuticals, Inc. | Administration of non oral androgenic steroids to women |
US7133717B2 (en) | 1999-08-25 | 2006-11-07 | Johnson & Johnson Consumer Companies, Inc. | Tissue electroperforation for enhanced drug delivery and diagnostic sampling |
US6522918B1 (en) | 2000-02-09 | 2003-02-18 | William E. Crisp | Electrolytic device |
JP2001286569A (en) | 2000-04-05 | 2001-10-16 | Polytronics Ltd | Endermism device |
IL136008A0 (en) | 2000-05-07 | 2001-05-20 | Elecsys Ltd | Electrically-mediated transdermal drug injection |
KR100433614B1 (en) * | 2000-06-16 | 2004-05-31 | 주식회사 태평양 | Transdermal Preparation Containing Hydrophilic or Salt-form Drug |
EP1315502B1 (en) | 2000-08-30 | 2010-03-17 | Unimed Pharmaceuticals, LLC | Method for treating erectile dysfunction and increasing libido in men |
US20030139731A1 (en) | 2002-01-23 | 2003-07-24 | Kevin Marchitto | Device for transcutaneous drug delivery and uses therefor |
US7647099B2 (en) | 2002-04-29 | 2010-01-12 | Rocky Mountain Biosystems, Inc. | Controlled release transdermal drug delivery |
AU2003276967A1 (en) | 2002-09-25 | 2004-04-19 | Flock, Stephen, T. | Microsurgical tissue treatment system |
-
2002
- 2002-10-31 IL IL152573A patent/IL152573A/en not_active IP Right Cessation
-
2003
- 2003-10-30 JP JP2004547954A patent/JP2006509739A/en active Pending
- 2003-10-30 EP EP03809829.9A patent/EP1556135B1/en not_active Expired - Lifetime
- 2003-10-30 AU AU2003276656A patent/AU2003276656A1/en not_active Abandoned
- 2003-10-30 WO PCT/IL2003/000902 patent/WO2004039427A2/en active Application Filing
-
2005
- 2005-04-27 US US11/116,065 patent/US7415306B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5993435A (en) * | 1990-04-30 | 1999-11-30 | Alza Corporation | Device and method of iontophoretic drug delivery |
US5320597A (en) * | 1991-02-08 | 1994-06-14 | Becton, Dickinson And Company | Device and method for renewing electrodes during iontophoresis |
US5983130A (en) * | 1995-06-07 | 1999-11-09 | Alza Corporation | Electrotransport agent delivery method and apparatus |
Also Published As
Publication number | Publication date |
---|---|
US7415306B2 (en) | 2008-08-19 |
AU2003276656A1 (en) | 2004-05-25 |
JP2006509739A (en) | 2006-03-23 |
AU2003276656A8 (en) | 2004-05-25 |
EP1556135B1 (en) | 2017-09-27 |
EP1556135A2 (en) | 2005-07-27 |
WO2004039427A2 (en) | 2004-05-13 |
IL152573A (en) | 2009-11-18 |
IL152573A0 (en) | 2003-05-29 |
EP1556135A4 (en) | 2011-03-30 |
US20050260252A1 (en) | 2005-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004039427A3 (en) | Transdermal delivery system for anti-emetic medication | |
WO2004000389A3 (en) | Rapidly dissolving micro-perforator for drug delivery and other applications | |
WO2005044224A3 (en) | Drug delivery system based on polymer nanoshells | |
WO2005051456A3 (en) | Composition and apparatus for transdermal delivery | |
WO2004039426A3 (en) | Transdermal delivery system for water insoluble drugs | |
WO2005120393A3 (en) | Implantable device for drug delivery and improved visibility | |
WO2005018702A3 (en) | Active agent delivery systems including a miscible polymer blend, medical devices, and methods | |
WO2005099667A3 (en) | Drug delivery compositions | |
AU2003258209A1 (en) | Active agent delivery systems, medical devices, and methods | |
AU2003262674A1 (en) | Active agent delivery system including a poly(ethylene-co-(meth)acrylate), medical device, and method | |
WO1999055312A3 (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
AU2003225735A1 (en) | Transdermal drug delivery patch system, method of making same and method of using same | |
WO2004091446A3 (en) | Medical device delivery systems | |
WO2005056075A3 (en) | Transdermal system for sustained delivery of polypeptides | |
WO2007065721A3 (en) | Hydrophilic coating comprising a polyelectrolyte | |
WO2004039428A3 (en) | Transdermal delivery system for dried particulate or lyophilized medications | |
WO2006133223A3 (en) | Implantable medical device with openings for delivery of beneficial agents with combination release kinetics | |
WO2004091444A3 (en) | Implantable medical device comprising therapeutic agents with different diffusion rates | |
AU2003217315A1 (en) | Coinless parking administration apparatus, system, and method | |
WO2005072709A3 (en) | Formulations for poorly soluble drugs | |
AU2001277120A1 (en) | Drug delivery and catheter systems, apparatus and processes | |
WO2006116718A3 (en) | Pharma-informatics system | |
WO2005041871A3 (en) | Apparatus and method for enhancing transdermal drug delivery | |
WO2005042051A3 (en) | Method for transdermal delivery of permeant substances | |
AU4757497A (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REEP | Request for entry into the european phase |
Ref document number: 2003809829 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003809829 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004547954 Country of ref document: JP Ref document number: 11116065 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2003809829 Country of ref document: EP |